Buscar resultados de ensayos clínicos

Patrocinado por

Fallopian Tube Diseases - 17 Studies Found

Estado Estudiar
Completed Nombre del estudio: Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography
Condición: Tubal Obstruction
Fecha: 2015-11-21
Intervenciones: Procedure: hysterosalpingography Starting procedure by using largest appropriate speculum for maximum ce
Completed Nombre del estudio: Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer Fecha: 2016-11-22
    Intervenciones:
    • Procedure: Baseline Biopsy Bas
Completed Nombre del estudio: Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx
Condición:
  • Hydrosalpinx
  • Infertility, Female

Fecha: 2016-11-23
Intervenciones: Drug: Isoamyl 2-Cyanoacrylate
Completed Nombre del estudio: Use of Essure® Micro-inserts in Women With Hydrosalpinx Prior to In Vitro Fertilization: A Prospective, Multicenter, International Feasibility Study
Condición: Women Who Suffer From Hydrosalpinx That is Causing Infertility and Whom Want a Safer Way of Treamtent
Fecha: 2010-10-04
Intervenciones: Device: Essure Micro Insert
Completed Nombre del estudio: Prevalence of HbA1C in Women With PCOS
Condición:
  • Polycystic Ovarian Syndrome
  • Pelvic Endometriosis
  • Insulin R
    Fecha: 2013-04-15
Completed Nombre del estudio: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Condición:
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Uterine En
    Fecha: 2016-03-31
    Intervenciones: Drug: Pembrolizumab Pembrolizumab 200mg IV Other Nam
Completed Nombre del estudio: A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
Condición:
  • Cancer Ovaries
  • Cancer Peritoneal
  • Cancer, Fallopian Tube Fecha: 2017-01-13
    Intervenciones:
    • Drug: OMP-305B83 intravenous (
Not yet recruiting Nombre del estudio: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Condición:
  • Advanced Cancer
  • Ovarian Cancer
  • Primary Peritoneal Carcinom
    Fecha: 2017-01-20
    Intervenciones:
    • Drug: Pembrolizumab Given intr
Completed Nombre del estudio: Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23
Condición: Ovarian Neoplasms
Fecha: 2016-08-26
Intervenciones:
  • Drug: Trabectedin Other Name:

Completed Nombre del estudio: A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer Fecha: 2016-06-29
Next >>>